CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 30 filers reported holding CANCER GENETICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DOMINI IMPACT INVESTMENTS LLC | 22,203 | $148,000 | 2.90% |
| Millrace Asset Group, Inc. | 187,184 | $1,250,000 | 1.30% |
| Sterneck Capital Management, LLC | 60,650 | $405,000 | 0.24% |
| GRUBER & MCBAINE CAPITAL MANAGEMENT LLC | 83,900 | $560,000 | 0.15% |
| Quality Growth Management, Inc. | 23,500 | $157,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $334,000 | 0.05% |
| DIKER MANAGEMENT LLC | 35,015 | $234,000 | 0.05% |
| SSI INVESTMENT MANAGEMENT LLC | 65,043 | $434,000 | 0.04% |
| BANK OF MONTREAL /CAN/ | 616,430 | $4,118,000 | 0.01% |
| Commonwealth Equity Services, Inc | 27,100 | $181,000 | 0.00% |